On Tuesday, Health Catalyst Inc (NASDAQ: HCAT) was 3.52% up from the session before settling in for the closing price of $8.23. A 52-week range for HCAT has been $5.42 – $11.41.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 21.79%. When this article was written, the company’s average yearly earnings per share was at 138.45%. With a float of $57.75 million, this company’s outstanding shares have now reached $58.30 million.
The extent of productivity of a business whose workforce counts for 1300 workers is very important to gauge. In terms of profitability, gross margin is 35.31%, operating margin of -25.19%, and the pretax margin is -28.74%.
Health Catalyst Inc (HCAT) Insider Updates
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Health Catalyst Inc stocks. The insider ownership of Health Catalyst Inc is 4.49%, while institutional ownership is 86.30%. The most recent insider transaction that took place on Oct 15 ’24, was worth 10,897. Before that another transaction happened on Oct 03 ’24, when Company’s Chief Operating Officer sold 5,209 for $7.68, making the entire transaction worth $40,011. This insider now owns 134,899 shares in total.
Health Catalyst Inc (HCAT) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 138.45% per share during the next fiscal year.
Health Catalyst Inc (NASDAQ: HCAT) Trading Performance Indicators
You can see what Health Catalyst Inc (HCAT) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 1.18. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.72.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.50, a number that is poised to hit 0.10 in the next quarter and is forecasted to reach 0.48 in one year’s time.
Technical Analysis of Health Catalyst Inc (HCAT)
The latest stats from [Health Catalyst Inc, HCAT] show that its last 5-days average volume of 0.36 million was inferior to 0.57 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 93.23%. Additionally, its Average True Range was 0.38.
During the past 100 days, Health Catalyst Inc’s (HCAT) raw stochastic average was set at 84.01%, which indicates a significant decrease from 89.23% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 33.42% in the past 14 days, which was lower than the 75.71% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $7.56, while its 200-day Moving Average is $7.60. Now, the first resistance to watch is $8.74. This is followed by the second major resistance level at $8.95. The third major resistance level sits at $9.25. If the price goes on to break the first support level at $8.22, it is likely to go to the next support level at $7.91. Assuming the price breaks the second support level, the third support level stands at $7.70.
Health Catalyst Inc (NASDAQ: HCAT) Key Stats
There are 59,035K outstanding shares of the company, which has a market capitalization of 515.20 million. As of now, sales total 295,940 K while income totals -118,150 K. Its latest quarter income was 75,900 K while its last quarter net income were -13,520 K.
